id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-P-0086-0011,FDA,FDA-2011-P-0086,Agency Response Letter to Risperidone Staleness,Other,Agency Response,2022-06-17T04:00:00Z,2022,6,2022-06-17T04:00:00Z,,2022-06-17T15:29:57Z,,0,0,09000064851793a1
FDA-2011-P-0086-0012,FDA,FDA-2011-P-0086,Agency Response Letter to Risperidone,Other,Agency Response,2022-06-17T04:00:00Z,2022,6,2022-06-17T04:00:00Z,,2022-06-17T15:31:43Z,,0,0,09000064851793a3
FDA-2011-P-0086-0009,FDA,FDA-2011-P-0086,"Supplement from Janssen Research & Development, LLC",Other,Electronic Regulation from Form,2016-12-07T05:00:00Z,2016,12,2016-12-07T05:00:00Z,,2016-12-07T19:51:18Z,,0,0,0900006482360a28
FDA-2011-P-0086-0008,FDA,FDA-2011-P-0086,Supplement from Janssen Research and Development,Other,Supplement (SUP),2016-02-26T05:00:00Z,2016,2,2016-02-26T05:00:00Z,,2016-02-26T16:00:23Z,,0,0,0900006481e881a5
FDA-2011-P-0086-0007,FDA,FDA-2011-P-0086,Supplement from Janssen,Other,Supplement (SUP),2016-02-16T05:00:00Z,2016,2,2016-02-16T05:00:00Z,,2016-02-16T20:34:21Z,,0,0,0900006481e6f4ee
FDA-2011-P-0086-0006,FDA,FDA-2011-P-0086,"Janssen Research & Development, LLC. - Supplement",Other,Supplement (SUP),2013-12-24T05:00:00Z,2013,12,2013-12-24T05:00:00Z,,2013-12-24T20:07:39Z,,0,0,09000064814ba9d1
FDA-2011-P-0086-0003,FDA,FDA-2011-P-0086,"Exhibit 3 - ""Diagnostic & Statistical Manual of Mental Disorders"" - [Johnson & Johnson Pharmaceutical Research, LLC., (Ropes & Gray, LLP) - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2011-02-23T05:00:00Z,2011,2,,,2011-02-23T21:39:03Z,,0,0,0900006480becf96
FDA-2011-P-0086-0001,FDA,FDA-2011-P-0086,"Johnson & Johnson Pharmaceutical Research, LLC., (Ropes & Gray, LLP) - Citizen Petition",Other,CP-Citizen Petition,2011-02-23T05:00:00Z,2011,2,2011-02-23T05:00:00Z,,2022-06-17T15:32:18Z,,0,0,0900006480becc27
FDA-2011-P-0086-0002,FDA,FDA-2011-P-0086,"Acknowledgement Letter to Johnson & Johnson Pharmaceutical Research, LLC., (Ropes & Gray, LLP)",Other,ACK-Acknowledgement Letter,2011-02-23T05:00:00Z,2011,2,2011-02-23T05:00:00Z,,2013-07-27T23:44:58Z,,0,0,0900006480becc2c